about
Synthetic peptide vaccines effective in preventing virus infection.A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years.Identification of Streptococcus mutans PAc peptide motif binding with human MHC class II molecules (DRB1*0802, *1101, *1401 and *1405).Determination of the agretopic residues of a peptide co-restricted to different class II isotypes, I-Au and I-Eu, and its application for preparation of a synthetic peptide vaccine against influenza virus A/Aichi/2/68.Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide.Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A strategy for making synthetic peptide vaccines.
@en
A strategy for making synthetic peptide vaccines.
@nl
type
label
A strategy for making synthetic peptide vaccines.
@en
A strategy for making synthetic peptide vaccines.
@nl
prefLabel
A strategy for making synthetic peptide vaccines.
@en
A strategy for making synthetic peptide vaccines.
@nl
P2093
P2860
P356
P1476
A strategy for making synthetic peptide vaccines.
@en
P2093
K Ogasawara
P2860
P304
P356
10.1073/PNAS.89.19.8995
P407
P577
1992-10-01T00:00:00Z